McIntyre, Freedman & Flynn Investment Advisers’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Buy |
32,189
+201
| +0.6% | +$15.9K | 1.8% | 18 |
|
|
2025
Q1 | $2.87M | Buy |
31,988
+1
| +0% | +$90 | 2.11% | 17 |
|
|
2024
Q4 | $3.18M | Buy |
31,987
+101
| +0.3% | +$10K | 2.38% | 12 |
|
|
2024
Q3 | $3.62M | Sell |
31,886
-75
| -0.2% | -$8.52K | 2.58% | 10 |
|
|
2024
Q2 | $3.96M | Sell |
31,961
-29
| -0.1% | -$3.59K | 2.85% | 6 |
|
|
2024
Q1 | $4.22M | Sell |
31,990
-574
| -2% | -$75.7K | 3.07% | 6 |
|
|
2023
Q4 | $3.55M | Buy |
32,564
+1
| +0% | +$109 | 2.84% | 6 |
|
|
2023
Q3 | $3.35M | Sell |
32,563
-99
| -0.3% | -$10.2K | 2.83% | 6 |
|
|
2023
Q2 | $3.77M | Sell |
32,662
-2,000
| -6% | -$231K | 3.22% | 5 |
|
|
2023
Q1 | $3.69M | Buy |
34,662
+1
| +0% | +$106 | 3.13% | 6 |
|
|
2022
Q4 | $3.85M | Buy |
+34,661
| New | +$3.85M | 3.18% | 7 |
|